Business
Ads for ‘misleading’ prostate supplements and home testing kits banned
Ads for prostate supplements and home testing kits have been banned over concerns they could mislead vulnerable people or steer them away from appropriate medical advice.
The Advertising Standards Authority (ASA) banned ads for four supplement brands – Nutrisslim, Nutreance, Muxue Trade and Impact Herbs – for making claims that their products could treat medical issues such as enlarged prostate, urinary flow problems or prostate inflammation.
None of the products were authorised medicines and advertising rules state that food products, including supplements, cannot make medicinal claims.
Nutreance, trading as Top 5 Supplements, said its ads did not state or imply that its product treated, cured or prevented any disease or medical symptoms, and the ads made no references to diseases, diagnoses, pathological conditions or clinical outcomes.
Nutrisslim, trading as Nature’s Finest by Nutrisslim, said the claims used in its ads related to botanical ingredients, which it understood could be used in advertising.
It said “visual materials” featuring a doctor and any related references had been removed from its website, including a reference to the product being “doctor-formulated”.
Impact Herbs, trading as Impact Supps, and Muxue did not respond to the ASA.
The ASA also banned ads from two home testing kit companies – Self Check and Lifelab Testing – for claiming that Prostate-Specific Antigen (PSA) tests could diagnose or rule out prostate cancer.
Self Check said its products were CE certified for self testing in line with UK legislation.
It further said that every product page contained a disclaimer that informed consumers that because the tests were not 100% at diagnosing a specific medical condition, they may wish to speak to their NHS GP first, who could arrange a test if needed.
It also said that it had removed the word “cancer” in the headings and descriptions of the Google ads for the product.
Lifelab also said it held the correct CE markings for an in-vitro diagnostic device, and that the product was suitable for sale in the UK.
It also said the ads had been removed and would not be used again.
A PSA test alone cannot do either, and in both cases the ads failed to make clear that these tests had limitations.
The ASA came across the ads during a sweep of healthcare claims using its AI-powered Active Ad Monitoring system.
The ASA said many of the claims it had seen in the latest investigations were “unacceptable”, and had not only broken a number of its rules but risked misleading vulnerable people, or steering those who needed it away from appropriate medical advice.
It said this was “especially worrying when it comes to men’s health”, adding that prostate symptoms could be worrying and, for some, difficult to talk about, meaning that ads promising quick fixes or simple answers “can seem even more appealing”.
However, misleading claims could give false reassurance or make it harder for people to know when to speak to a doctor, “which is why it’s so important that information about prostate health is accurate and responsible”, the ASA said.
Jess Tye, regulatory projects manager at the ASA, said: “When it comes to health, people deserve honesty.
“Misleading ads about prostate supplements or tests can cause real harm, and today’s rulings hold advertisers to account.
“We’re continuing to monitor this sector closely, using our AI tools to spot problem ads early on. And if someone does have a concern about an ad they’ve seen, we’d encourage them to get in touch.”
Joseph Burt, head of diagnostics and general medical devices at the Medicines and Healthcare products Regulatory Agency (MHRA), said: “The MHRA welcomes the ASA’s action to tackle misleading claims about PSA home-testing kits.
“At-home or over-the-counter PSA tests help members of the public monitor their prostate health, but are not a definitive test for prostate cancer. These tests must not claim to detect prostate cancer, and consumers should carefully check the labelling and read the instructions for use.
“The MHRA has recognised the expansion of over-the-counter tests, including PSA tests.
“As part of our surveillance of medical devices, we continue to monitor the safety of these devices. Manufacturers of these tests have an important role in ensuring information about direct-to-consumer tests are put into context for the general public who use these tests as well as monitoring the use of the tests.”
Amy Rylance, assistant director of health improvement at Prostate Cancer UK, said: “We are very pleased to see the ASA getting proactive in identifying and banning these dangerous and misleading adverts.
“There is no evidence that supplements can treat, cure or prevent prostate problems, and they should not be used in place of speaking to a doctor about your risk of prostate cancer, or more general concerns about your prostate health.
“While there are a range of at-home PSA self-test kits on the market currently, the accuracy and safety of these tests is not proven, and so we only recommend getting a PSA blood test from a healthcare professional.
“It’s important to remember that prostate cancer often has no symptoms in its earlier, more treatable stages, so it’s crucial for a man to understand his own risk and not to wait for potential signs or symptoms. Any men worried about their risk of prostate cancer or looking to find out more about testing can take Prostate Cancer UK’s 30-second online Risk Checker.”
Consumers can check the registration status of PSA tests via the MHRA’s Public Access Registrations Database.
Anyone concerned about the quality or safety of a PSA test should report it to the MHRA via the Yellow Card scheme.
Business
Harry Styles and Anthony Joshua among UK’s top tax payers
The former One Direction member-turned-solo artist appears on the Sunday Times list for the first time.
Source link
Business
From Manufacturing To Infra And AI: Capex Boost Flags Off Budget 2026 ‘Reforms Express’
Last Updated:
Budget 2026: FM Nirmala Sitharaman gives a strong push to manufacturing, infrastructure and job creation, while proposing a simpler tax and customs system.
Finance Minister Nirmala Sitharaman presents the Union Budget 2026-27.
Budget 2026 Takeaways: Finance Minister Nirmala Sitharaman on Sunday presented the Union Budget 2026-27, giving a strong push to manufacturing, infrastructure and job creation, proposing a simpler tax and customs regime, and hailing the government’s modernisation drive as a “reforms express”.
The Budget 2026 is anchored around three ‘kartavyas’ — driving growth by enhancing productivity and competitiveness, building people’s capacity, and ensuring inclusive development under the vision of Sabka Saath, Sabka Vikaas.
In her ninth consecutive Budget in Parliament, Sitharaman laid out a multi-pronged strategy to sustain growth amid global uncertainty, including expanding domestic electronics and semiconductor capabilities, de-risking infrastructure projects, skilling India’s youth for emerging technologies, and easing compliance for taxpayers and importers.
Here are the key takeaways from Budget 2026 across manufacturing, infrastructure, skills, AI, taxation and customs duty.
Manufacturing Gets A Boost
Budget 2026 put a special emphasis on the manufacturing landscape in India. The outlay for electronics components manufacturing was raised sharply to Rs 40,000 crore, while new schemes for rare earth magnets, chemical parks, container manufacturing and capital goods seek to reduce import dependency, and strengthen domestic supply chains. Textiles got an integrated, employment-oriented package covering fibres, clusters, skilling and sustainability.
Infrastructure-Led Growth
Infrastructure got a boost with a higher capex allocation and initiatives like a risk guarantee fund to de-risk projects for private developers, new dedicated freight corridors and national waterways, dedicated REITs (real estate investment trusts) for recycling of significant real estate assets of central public sector enterprises (CPSEs), and a seaplane VGF (viability gap funding) scheme.
The Centre’s capital expenditure (capex) target has been increased to Rs 12.2 lakh crore for FY27, up from Rs 11.2 lakh crore earmarked for the current financial year. Moreover, maintaining the fiscal discipline, Sitharaman said the government expects the fiscal deficit to be at 4.3 per cent of the GDP in 2026-27, lower than 4.4 per cent projected for the current financial year.
Tier-II and Tier-III cities were placed at the centre of urban growth via City Economic Regions, backed by reform-linked funding.
“We shall continue to focus on developing infrastructure in cities with over 5 lakh population (Tier II and Tier III), which have expanded to become growth centres,” Sitharaman said in her Budget Speech.
Greater Emphasis On Skilling
The Budget placed renewed emphasis on the services economy as a jobs engine. A high-powered Education-to-Employment and Enterprise Committee will realign skilling with market needs, including the impact of emerging technologies.
Content creation and creative industries get a boost through AVGC labs in schools and colleges, support for animation, gaming and comics, and new institutional capacity for design and hospitality. Tourism-linked skilling, from guides to digital heritage documentation, signals a clear intent to convert culture and content into employment and exports.
“I propose to support the Indian Institute of Creative Technologies, Mumbai in setting up AVGC Content Creator Labs in 15,000 secondary schools and 500 colleges,” FM Sitharaman said. AVGC stands for animation, visual effects, gaming and comics.
AI & Semiconductors Push
Artificial intelligence (AI) was positioned as a cross-sector force multiplier rather than a standalone theme. The Budget provided a push to artificial intelligence (AI) by promoting adoption with governance, agriculture, education and skilling, including proposals for AI-enabled advisory tools for farmers and AI integration in education curricula.
On hardware, the semiconductor strategy expanded decisively under ISM 2.0 (India Semiconductor Mission 2.0), with focus on domestic equipment manufacturing, materials, research centres and workforce development, signalling a long-term commitment to building a resilient chip ecosystem in India.
Taxation, ITR, TDS, TCS
A major structural reform comes with the Income Tax Act, 2025, effective April 1, 2026, containing simpler rules and redesigned forms.
Budget 2026 provided compliance relief for individuals, including extended timelines for revising returns to March 31 from December 31 earlier, staggered ITR due dates, and easier filing of Form 15G/15H through depositories.
Individuals with ITR-1 and ITR-2 returns will continue to file till July 31, and non-audit business cases or trusts are proposed to be allowed time till August 31, according to the Budget Speech 2026-27.
“I propose to extend time available for revising returns from 31st December to up to 31st March with the payment of a nominal fee. I also propose to stagger the timeline for filing of tax returns. Individuals with ITR 1 and ITR 2 returns will continue to file till 31st July and non-audit business cases or trusts are proposed to be allowed time till 31st August,” Sitharaman said.
TDS (Tax deducted at source) rules were clarified for manpower services, while a rule-based system for lower or nil TDS certificates is proposed. TCS rates were cut to 2% for overseas tour packages, education and medical expenses under liberalised remittance scheme (LRS). Litigation is targeted through integrated assessment and penalty orders, lower pre-deposit requirements, and wider immunity provisions.
TDS on the sale of immovable property by a non-resident will be deducted and deposited through resident buyer’s PAN (Permanent Account Number)-based challan instead of requiring TAN (Tax Deduction and Collection Account Number), Sitharaman said.
Customs Duty Tweaks
Customs duty rationalisation continued with a clear focus on domestic manufacturing, energy transition and ease of living. Exemptions have been extended or introduced for capital goods used in lithium-ion batteries, critical minerals processing, nuclear power projects and aircraft manufacturing.
Personal imports will become cheaper with a reduction in duty on goods for personal use from 20% to 10%. Seventeen cancer drugs and additional rare-disease treatments were exempted from customs duty. Process reforms aimed at trust-based, tech-driven clearances, faster cargo movement and lower compliance costs, especially for exporters and MSMEs (micro, small, medium and enterprises).
STT On F&O Hiked
The Budget increased securities transaction tax (STT) on futures trading from 0.02% to 0.05% and on options trading from 0.10% to 0.15%, a move that upset the capital markets with the BSE Sensex crashing more than 2,300 points from the day’s high and the NSE Nifty dropping to 24,571.75.
Securities Transaction Tax (STT) is a direct tax imposed on the buying and selling of securities in India.
Commenting on the Budget, Prime Minister Narendra Modi said, “The Union Budget reflects the aspirations of 140 crore Indians. It strengthens the reform journey and charts a clear roadmap for Viksit Bharat.”
February 01, 2026, 14:43 IST
Read More
Business
Air India resumes direct Shanghai-New Delhi flights after nearly six years
Shanghai (China): The Consulate General of India in Shanghai welcomed the resumption of Air India’s direct flight services between Shanghai and New Delhi, marking a major step forward in restoring people-to-people, business and institutional connectivity between India and China.
According to an official release, the inaugural Shanghai-New Delhi flight departed today from Shanghai Pudong International Airport, carrying over 230 passengers on board the Boeing 787 aircraft. The relaunch comes after a gap of nearly six years and represents a significant milestone in normalising bilateral air connectivity following the suspension of services in early 2020.
Speaking on the occasion, Consul General Pratik Mathur said, “The resumption of direct flights between Shanghai and New Delhi is a tangible expression of the renewed momentum in India-China engagement. Enhanced air connectivity is essential for facilitating trade, tourism, academic exchanges and people-to-people contacts, particularly between India and East China. We are pleased to see Air India restoring this important link.”
As per a release, Air India will operate the route four times a week using its Boeing 787-8 Dreamliner aircraft, featuring modernised cabins and enhanced onboard services. The restored service reflects the growing demand for travel between the two countries and the steady recovery of cross-border mobility. It will also support commercial, educational and cultural exchanges between India and the Yangtze River Delta region, one of China’s most economically dynamic clusters.
The Consulate General of India in Shanghai remains committed to supporting initiatives that strengthen connectivity and deepen cooperation across trade, investment, tourism, education and cultural exchange, the release stated.
-
Sports5 days agoPSL 11: Local players’ category renewals unveiled ahead of auction
-
Tech1 week agoThis Mega Snowstorm Will Be a Test for the US Supply Chain
-
Entertainment5 days agoClaire Danes reveals how she reacted to pregnancy at 44
-
Tech1 week ago‘Uncanny Valley’: Donald Trump’s Davos Drama, AI Midterms, and ChatGPT’s Last Resort
-
Fashion1 week agoSpain’s apparel imports up 7.10% in Jan-Oct as sourcing realigns
-
Tech1 week agoICE Asks Companies About ‘Ad Tech and Big Data’ Tools It Could Use in Investigations
-
Sports5 days agoCollege football’s top 100 games of the 2025 season
-
Fashion1 week agoTurkiye cuts benchmark rate to 37%, flags confidence on inflation
